Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
BMC Neurology
|
June 3, 2014
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
Peter W Thomas, Sarah Thomas, Paula Kersten, et al.
Cancer Chemotherapy and Pharmacology
|
February 18, 2016
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
Steven J Cohen, Bert H O'Neil, Jordan Berlin, et al.
Frontiers in Neurology
|
April 25, 2024
People with newly diagnosed multiple sclerosis benefit from a complex preventative intervention-a single group prospective study with follow up
Natália Hrušková, Kateřina Berchová Bímová, Angela Davies Smith, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 23, 2013
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
Sarah Thomas, Peter W Thomas, Paula Kersten, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 24, 2012
The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. 1993
David Vetrie, Igor Vořechovský, Paschalis Sideras, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
Mark G Kris, Giuseppe Giaccone, Angela Davies, et al.
BMJ Open
|
August 23, 2023
Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment
Sally-Anne Dews, Adit Bassi, Sean Buckland, et al.
JMIR Formative Research
|
May 24, 2019
Digitizing a Face-to-Face Group Fatigue Management Program: Exploring the Views of People With Multiple Sclerosis and Health Care Professionals Via Consultation Groups and Interviews
Sarah Thomas, Andy Pulman, Peter Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 27, 2011
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial
Barbara J Gitlitz, Denice D Tsao-Wei, Susan Groshen, et al.
Cancer Journal (Sudbury, Mass.)
|
November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California
Cynthia L Martel, Yueju Li, Laurel Beckett, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
BMC Neurology
|
June 3, 2014
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
Peter W Thomas, Sarah Thomas, Paula Kersten, et al.
Cancer Chemotherapy and Pharmacology
|
February 18, 2016
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
Steven J Cohen, Bert H O'Neil, Jordan Berlin, et al.
Frontiers in Neurology
|
April 25, 2024
People with newly diagnosed multiple sclerosis benefit from a complex preventative intervention-a single group prospective study with follow up
Natália Hrušková, Kateřina Berchová Bímová, Angela Davies Smith, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 23, 2013
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
Sarah Thomas, Peter W Thomas, Paula Kersten, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 24, 2012
The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. 1993
David Vetrie, Igor Vořechovský, Paschalis Sideras, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
Mark G Kris, Giuseppe Giaccone, Angela Davies, et al.
BMJ Open
|
August 23, 2023
Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment
Sally-Anne Dews, Adit Bassi, Sean Buckland, et al.
JMIR Formative Research
|
May 24, 2019
Digitizing a Face-to-Face Group Fatigue Management Program: Exploring the Views of People With Multiple Sclerosis and Health Care Professionals Via Consultation Groups and Interviews
Sarah Thomas, Andy Pulman, Peter Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 27, 2011
A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial
Barbara J Gitlitz, Denice D Tsao-Wei, Susan Groshen, et al.
Cancer Journal (Sudbury, Mass.)
|
November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California
Cynthia L Martel, Yueju Li, Laurel Beckett, et al.
Page
of 7